https://washoe-nv.legistar.com/Gateway.aspx?M=LD&From=RSS&ID=4972652&GUID=AD7FE36E-545A-4C22-9DC5-198507EB2FF3Legistar15https://washoe-nv.legistar.com/Gateway.aspx?M=LD&From=RSS&ID=4972652&GUID=AD7FE36E-545A-4C22-9DC5-198507EB2FF3AD7FE36E-545A-4C22-9DC5-198507EB2FF3-2026-02-02-19-21-16Title: Update from outside counsel for Washoe County on various opioid litigation related cases and issues including: (1) Washoe County v. Teva Pharmaceuticals, et. al., CV20-01142, filed in the Second Judicial District Court; (2) the status of other national opioid litigation cases in other jurisdictions; (3) update on a settlement between the State of Nevada and other states with McKinsey and Co., (4) discussion on developments in opioid related bankruptcy filings by opioid companies including Purdue Pharma and (5) possible action to direct counsel for Washoe County to cast its vote to approve a bankruptcy plan consistent with other members of the Multi-State Government Entities (“MSGE”) in the Purdue Pharma Bankruptcy Case No. 19-23649 filed in the United States Bankruptcy Court Southern District Of New York. The MSGE consists of attorneys representing similarly situated cities and counties who coordinate legal strategies and exchange information about opioid lawsuits. The bankruptcy plan provisions are included in a May 15, 2021 draft entitled “National Opioid Abatement Trust DistribMon, 02 Feb 2026 19:21:16 GMT